BROADWAY FINANCIAL CORP quarterly report, Q1 FY2013

Broadway Financial Corporation — Q1 2013 Form 10-Q

Business context and period: The filing covers the three months ended March 31, 2013, with balance-sheet comparisons to December 31, 2012. Broadway Financial is a bank holding company whose subsidiary, Broadway Federal Bank, operates under formal regulatory orders. Amounts below are in U.S. dollars; financial statement amounts are generally in millions unless noted.

Financial performance and condition

MetricQ1 2013 / Mar. 31, 2013Comparable period / Dec. 31, 2012
Interest income$4.0 million$5.5 million in Q1 2012
Net interest income before provision$2.7 million$3.7 million in Q1 2012
Net interest marginDown 64 basis points year over year; filing text does not provide a clear margin value—
Net income (loss)$(616,000); loss available to common shareholders $(931,000), or $(0.49) per basic and diluted share$154,000 net income in Q1 2012; loss available to common shareholders $(132,000), or $(0.08) per share
Operating cash flow$1.2 million$1.8 million in Q1 2012
Total assets$363.1 million$373.7 million at Dec. 31, 2012
Cash and cash equivalents$75.8 million$64.4 million at Dec. 31, 2012
Loans held for investment, net$235.1 million$251.7 million at Dec. 31, 2012
Deposits$247.6 million$257.1 million at Dec. 31, 2012
Borrowings$90.5 million: $79.5 million FHLB advances, $6.0 million subordinated debentures, and $5.0 million other borrowingsUnchanged from Dec. 31, 2012
Shareholders’ equity$17.2 million$18.0 million at Dec. 31, 2012
  • Net interest income fell 27% year over year, principally as average interest-earning assets and loan yields declined. Interest expense also declined, aided by lower deposit costs and lower FHLB borrowing costs.
  • Total non-interest expense rose to $3.5 million from $2.9 million, including a $470,000 provision for losses on loans held for sale. Non-interest income fell to $221,000 from $423,000, mainly because gains on REO sales were lower.
  • No provision for investment-loan losses was recorded in Q1 2013, versus $959,000 in Q1 2012. Loan charge-offs were $1.8 million, versus $644,000 a year earlier; the allowance for loan losses ended at $10.45 million.
  • Non-performing assets were $36.1 million, or 9.95% of assets, at quarter-end, compared with $45.3 million, or 12.11%, at year-end. Non-accrual loans were $26.8 million; total delinquent loans were $31.2 million. The company reported lower delinquency and impairment trends, but cautioned that actual losses could exceed estimates.
  • Q1 cash increased by $11.4 million: investing activities provided $20.0 million, financing activities used $9.8 million, and operating activities provided $1.2 million. Investing inflows included loan-sale proceeds and principal collections; financing outflows primarily reflected deposit decline.

Material changes, outlook, and risks

  • Portfolio reduction: Management pursued sales of non-performing and classified loans. It reported $9.3 million of loan sales during Q1 and transferred $6.2 million of loans to held-for-sale. A separate bulk sale of multi-family and commercial real estate loans closed in Q2; pro forma figures reduced quarter-end NPAs to $30.0 million and TDRs to $32.4 million. The filing does not provide a complete set of transaction terms in the supplied text.
  • Deposits and liquidity: Deposits declined $9.4 million, including a $13.0 million reduction in certificates of deposit, partly offset by a $3.6 million increase in core deposits. The Bank reported $75.8 million in cash and cash equivalents and $10.7 million of unpledged securities. It had approval to borrow up to $3.5 million more from the FHLB, subject to collateral and stock requirements.
  • Going-concern warning: Management states that conditions raise substantial doubt about the Company’s ability to continue as a going concern. The holding company lacks cash to meet operating expenses and obligations; it cannot rely on Bank dividends without regulatory approval, which management says is unlikely. The Company is deferring interest on its $6.0 million subordinated debentures and is in default on its $5.0 million line of credit. The debentures mature in March 2014.
  • Recapitalization is uncertain: Management was pursuing exchanges of Treasury and other preferred securities for common stock or equivalents, a partial exchange of senior debt, forgiveness of accrued line-of-credit interest, and new equity placements of at least $5 million (or approximately $4 million if Treasury approves). Illustratively, at $1 per share, the plan could issue about 18 million new shares—approximately 90% of pro forma shares—and require shareholder approval to increase authorized shares. There is no assurance the plan will close or succeed.
  • Regulatory constraints: Cease-and-desist orders require the Bank to maintain Tier 1 core capital to adjusted assets of at least 8% and total risk-based capital of at least 12%, restrict dividends and debt actions, and limit asset growth and brokered deposits. At March 31, the Bank reported ratios of 9.00% and 15.22%, respectively, meeting those order thresholds. Management warns that failure to maintain required capital could lead to further action, including a conservator or receiver.
  • Other risks and unusual matters: A former loan officer remained the subject of an OTS investigation concerning loan documentation and possible unauthorized benefits; the company says it reviewed the loans and reflected relevant information in its loss estimates. The filing reports a $9.4 million deferred-tax valuation allowance and no net deferred tax asset. Management provided no financial forecast or earnings guidance.

Important facts for investors to verify

  • Whether the recapitalization, equity raise, preferred-stock exchanges, debt exchange, and required shareholder approvals were completed, and the final dilution and ownership impact.
  • Current status of the going-concern uncertainty, regulatory orders, capital ratios, and any restrictions or enforcement actions.
  • Final terms and realized impact of the Q2 bulk loan sale, including effects on NPAs, TDRs, loan-loss provisions, and future earnings.
  • Progress in resolving the defaulted credit line and deferred subordinated-debt interest, including the March 2014 maturity.
  • Subsequent asset-quality performance, collateral valuations, charge-offs, and adequacy of the $10.45 million loan-loss allowance.